ARTICLE | Company News
Cornerstone Therapeutics, Targacept deal
August 9, 2010 7:00 AM UTC
Cornerstone granted Targacept exclusive, worldwide rights to its nicotinic receptor patents and preclinical compounds that target the receptors, including nicotinic acetylcholine receptor alpha 7 (C...